You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Doubling the dose of inhaled corticosteroids during asthma deterioration did not improve asthma control

https://doi.org/10.1136/ebm.9.5.140

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • ↵* See glossary.

    • For correspondence: Dr T W Harrison, Nottingham City Hospital, Nottingham, UK. tharris2ncht.trent.nhs.uk

    • Sources of funding: NHS Executive. Active and placebo corticosteroid inhalers provided by AstraZeneca, GlaxoWellcome, 3M, and Baker Norton.